Sarah L Blair

3PUBLICATIONS
48CO-AUTHORS
Molecular targetsSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 18, 2023
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.

Kathy S Albain, Christina Yau, Emanuel F Petricoin

|Dec 13, 2021
Breast cancer-The catalyst of contemporary trials design.

Zahraa Al-Hilli, Anna Weiss, Ava Armani

|Nov 12, 2020
Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes.

Sasha R Halasz, Thomas O'Keefe, Anne M Wallace

Pageof 1